Human medicines European public assessment report (EPAR): Phesgo, pertuzumab,trastuzumab, Date of authorisation: 21/12/2020, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Votrient, pazopanib, Date of authorisation: 14/06/2010, Revision: 32, Status: Authorised
Advanced therapy classification
Article 57 product data
Agenda - ACT EU multi-stakeholder platform annual meeting - October 2025
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes
Template for sharing EMA documents by Industry to support reliance
Human medicines European public assessment report (EPAR): Abilify Maintena, aripiprazole, Date of authorisation: 14/11/2013, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Multaq, dronedarone, Date of authorisation: 25/11/2009, Revision: 22, Status: Authorised